Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT02249676 · COMPLETED

Trial details

NCT number: NCT02249676
Sponsor: Tianjin Medical University General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Devic's Syndrome Devic's Neuromyelitis Optica Devic Syndrome Devic's Disease Devic Disease

Start date: 2013-01-01
Primary completion: 2014-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.